Hereditary inclusion-body myopathy
MONDO:0016112Also known as: inclusion myopathy, cytoplasmic body myopathy
8 clinical trials for this condition and its sub-types, 1 tagged with Hereditary inclusion-body myopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Hereditary inclusion-body myopathy
-
GNE myopathy 3 trials
-
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia 1 trial · 3 incl. sub-types
4 sub-types
- Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1 2 trials
- Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2 1 trial
- Inclusion body myopathy and brain white matter abnormalities 0 trials
- Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3 0 trials
-
1 sub-type
-
New drug UX016 targets rare muscle disease
Disease control Recruiting nowThis early-stage trial tests UX016, a drug designed to help people with GNE myopathy, a rare genetic muscle-weakening disease. Researchers will give the drug or a placebo to 24 adults to see if it is safe and improves muscle strength. The study is not yet recruiting.
Phase 1/2 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New handheld scanner could replace MRI for muscle disease monitoring
Diagnosis Recruiting nowThis study is testing a handheld device called mScan that uses a tiny, painless electrical current to measure muscle health. Researchers want to see if it can give similar results to an MRI, but faster and more conveniently. The study involves 150 adults with and without muscle d…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
Wearable tech tracks fatigue in muscle disease patients
Knowledge-focused Recruiting nowThis study aims to find better ways to measure fatigue and walking problems in people with neuromuscular diseases like muscular dystrophy and spinal muscular atrophy. Researchers will use a wearable sensor to track physical activity for one week in daily life and during a walking…
Sponsor: IRCCS Eugenio Medea • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC